Barbara Carnemolla Selected Research

Barbara Carnemolla Research Topics

Disease

20	Neoplasms (Cancer) 01/2020 - 03/2002
4	Carcinoma (Carcinomatosis) 08/2019 - 04/2006
2	Melanoma (Melanoma, Malignant) 11/2015 - 05/2013
2	Neoplasm Metastasis (Metastasis) 03/2015 - 09/2011
2	Necrosis 08/2013 - 07/2010
2	Fibrosarcoma 08/2013 - 04/2006
2	Neuroblastoma 07/2010 - 08/2004
1	Glioma (Gliomas) 03/2015
1	Osteosarcoma (Osteogenic Sarcoma) 08/2013
1	Fibrosis (Cirrhosis) 12/2012
1	Lung Diseases (Lung Disease) 12/2012
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2012
1	Wounds and Injuries (Trauma) 12/2012
1	Disease Progression 12/2012
1	Idiopathic Pulmonary Fibrosis 12/2012
1	Lung Injury 12/2012
1	Arthritis (Polyarthritis) 11/2011
1	Carcinogenesis 01/2009
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2008
1	Medulloblastoma 11/2007
1	Prostatic Neoplasms (Prostate Cancer) 11/2005
1	Astrocytoma (Pilocytic Astrocytoma) 11/2002
1	Vascular Tissue Neoplasms 03/2002

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 08/2019 - 03/2002
7	Fibronectins (Fibronectin)IBA 08/2019 - 03/2002
4	Interleukin-2 (IL2)IBA 08/2019 - 03/2002
4	Protein Isoforms (Isoforms)IBA 08/2019 - 03/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2010 - 12/2003
3	Immunoglobulin FragmentsIBA 01/2020 - 12/2003
3	Syndecan-1 (Syndecan 1)IBA 08/2019 - 05/2013
3	PeriostinIBA 03/2015 - 09/2011
3	Melphalan (Alkeran)FDA LinkGeneric 08/2013 - 04/2006
2	L19-IL2 immunocytokineIBA 08/2019 - 11/2015
2	CytokinesIBA 01/2018 - 03/2002
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 11/2015 - 05/2013
2	Biomarkers (Surrogate Marker)IBA 12/2012 - 01/2008
2	LigandsIBA 11/2007 - 02/2005
1	Peptides (Polypeptides)IBA 01/2020
1	Single-Chain AntibodiesIBA 01/2018
1	Gemcitabine FDA Link 08/2013
1	IntegrinsIBA 12/2012
1	Bleomycin (Blenoxane)FDA LinkGeneric 12/2012
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2012
1	CollagenIBA 11/2011
1	Extracellular Matrix ProteinsIBA 09/2011
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 09/2011
1	Therapeutic UsesIBA 07/2010
1	RNA Precursors (Precursor, mRNA)IBA 02/2010
1	ChromatinIBA 01/2009
1	Matrix Attachment Region Binding ProteinsIBA 01/2009
1	Nuclear Matrix-Associated ProteinsIBA 11/2005
1	NectinsIBA 02/2005
1	Surface Antigens (Surface Antigen)IBA 08/2004
1	3-hydroxy-5-estrane-17-carbonitrile (ACN)IBA 08/2004
1	Factor VIII (Coagulation Factor VIII)IBA 11/2002
1	AntibodiesIBA 11/2002
1	Immunoglobulin G (IgG)IBA 11/2002
1	Staphylococcal Protein A (Protein A)IBA 03/2002
1	Interferon-gamma (Interferon, gamma)IBA 03/2002

Therapy/Procedure

9	Therapeutics 01/2020 - 12/2003
1	Drug Therapy (Chemotherapy) 01/2020
1	Immunotherapy 01/2020
1	Aftercare (After-Treatment) 12/2007